U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Processes for producing tumor necrosis factor

Patent 5487984 Issued on January 30, 1996. Estimated Expiration Date: Icon_subject January 30, 2013. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

Anti-tumor agent from human serum and process
Patent #: 4309418
Issued on: 01/05/1982
Inventor: Green

Human tumor necrosis factor
Patent #: 4677064
Issued on: 06/30/1987
Inventor: Mark ,   et al.

Telephone answering and call forwarding improvement
Patent #: 4677663
Issued on: 06/30/1987
Inventor: Szlam

Novel human physiologically active polypeptide
Patent #: 4879226
Issued on: 11/07/1989
Inventor: Wallace, et al.

Method for purifying a physiologically active substance produced by recombinant DNA technique
Patent #: 4880915
Issued on: 11/14/1989
Inventor: Kajihara, et al.

Expression systems for overproduction of desired proteins Patent #: 5182196
Issued on: 01/26/1993
Inventor: Allet, et al.

Inventors

Assignee

Application

No. 811654 filed on 12/20/1985

US Classes:

435/69.5, Lymphokines or monokines435/252.33, Escherichia (e.g., E. coli, etc.)435/254.11, Transformants435/320.1, VECTOR, PER SE (E.G., PLASMID, HYBRID PLASMID, COSMID, VIRAL VECTOR, BACTERIOPHAGE VECTOR, ETC.) BACTERIOPHAGE VECTOR, ETC.)536/23.5, Encodes an animal polypeptide536/24.1Non-coding sequences which control transcription or translation processes (e.g., promoters, operators, enhancers, ribosome binding sites, etc.)

Examiners

Primary: Allen, Marianne P.

Attorney, Agent or Firm

Foreign Patent References

  • 4871663 Ohima et al. 10/13/1089
  • WO8401288 WO. 04/13/1984

International Classes

C12N 015/00
C12N 015/19

Abstract

A process of producing mammalian tumor necrosis factors (TNF) and TNF-like polypeptides by culturing eukaryotic or prokaryotic hosts transformed with DNA sequences encoding those polypeptides. A process for purifying TNF-like polypeptides using an anion exchanger. The TNFs and TNF-like polypeptides produced by the processes of this invention, and compositions and methods utilizing those TNFs and TNF-like polypeptides, are useful in anticancer, antitumor and antimalarial therapies. They are also useful together with interferon therapy, chemotherapy in anticancer and antitumor therapies, and in combination with actinomycin D in the treatment of tumor-bearing mammals.

Other References

  • G. R. Adolf and I. Fogy, "Purification And Characterization Of A Cytotoxic Human Protein (Lymphotoxin/Tumor Necrosis Factor)", 4th International Lymphokine Workshop, Lymphokine Res., 3(4), p. 231 (1984)
  • N. Bloksma et al., "Endotoxin-Induced Release Of Tumour Necrosis Factor And Interferon In Vivo Is Inhibited By Prior Adrenoceptor Blockade," Cancer Immunol Immunother, 14, pp. 41-45 (1982) (Bloksma I)
  • N. Bloksma et al., "Antitumour Activity Of Endotoxin, Concanavalin A and poly I:C And Their Ability To Elicit Tumour Necrosis Factor, Cytostatic Factors, And Interferon In Vivo," Cancer Immunol Immunother, 16, pp. 35-39 (1983) (Bloksma II)
  • E. A. Carswell et al., "An Endotoxin-Induced Serum Factor That Causes Necrosis of Tumors," Proc. Natl. Acad. Sci. USA, 72, pp. 3666-3670 (1975)
  • G. A. Currie and C. Basham, "Activated Macrophages Release A Factor Which Lyses Malignant Cells But Not Normal Cells," J. Exp. Med., 142, pp. 1600-1605 (1975)
  • G. A. Currie, "Activated Macrophages Kill Tumor Cells By Releasing Arginase", Nature, 273, pp. 758-759 (1978)
  • N. Fiore et al., "Tumor Necrosis Factor: Further Studies," Proc. Am. Assoc. Cancer Res. (Abstract 498), 16, p. 125 (1975)
  • N. Freudenberg et al., "Haemorrhagic Tumor Necrosis Following Endotoxin Administration," Virchows Arch, 403, pp. 377-389 (1984)
  • F. de-Germain Matteis and G. R. Burleson, "Comparison And Characterization Of Gamma Interferon And Tumor Necrosis Factor In The Rat System," Fed. Proc., 41(3), Abst. 1012 (1982)
  • S. Green et al., "Mechanism of Endotoxin-Induced Tumor Hemorrhagic Necrosis," AACR Abstracts (Abstract 554), 15, p. 139 (1974)
  • S. Green et al., "Partial Purification of a Serum Factor That Causes Necrosis of Tumors," Proc. Nat. Acad. Sci. USA, 72, pp. 381-385 (1976)
  • S. Green et al., "Necrosis of Meth A tumors by a Factor From Liver of C. parvum (CP) Endotoxin-Treated Mice," (Abstract) AACR Abstracts (Immunology) 17, p. 84 (1976)
  • **S. Green et al., "Evidence For The Presence Of An Antitumor Factor In Serum Of Normal Aminals", Cancer Letters, 6, pp. 235-240 (1979)
  • S. Green et al. "Action Of Tumor Necrosis Factor (TNF) On Mouse Myelomonocytic Leukemia (WEHI/3) In Vitro And In Vivo," AACR Abstracts (Immunology) p. 294 (1981)
  • S. Green et al., "Murine Tumor Necrosis-Inducing Factor: Purification And Effects On Myelomonocytic Leukemia Cells," JNCI, 68, pp. 997-1003 (1982)
  • J. Hammerstrom, "Soluble Cytostatic Factor(s) Released from Human Monocytes: I. Production and Effect on Normal and Transformed Human Target Cells," Scand. J. Immunol., 15, pp. 311-318 (1982)
  • C. G. Haidaris et al., "Serum Containing Tumor Necrosis Factor Is Cytotoxic For The Human Malaria Parasite Plasmodium falciparum," Infection and Immunity, 42, pp. 385-393 (1988)
  • K. Haranaka and N. Satomi, "Note: Cytotoxic Activity of Tumor Necrosis Factor (TNF) on Human Cancer Cells in vitro," Japan J. Exp. Med., 51, pp. 191-194 (1981)
  • K. Haranaka et al., "Antitumor Activity Of Murine Tumor Necrosis Factor (TNF) Against Transplanted Murine Tumors And Heterotransplanted Human Tumors In Nude Mice," Int. J. Cancer, 34, pp. 263-267 (1984)
  • K. Haranaka et al., "Differences In Tumour Necrosis Factor Productive Ability Among Rodents," Br. J. Cancer, 50, pp. 471-478 (1984)
  • K. Haranaka et al., "Role of First Stimulating Agents In The Production Of Tumor Necrosis Factor," Cancer Immunol Immunother, 18, pp. 87-90 (1984)
  • L. Helson et al., "Effects of Murine Tumour Necrosis Factor on Cultured Human Melanoma Cells," Nature (London), 258, pp. 731-732 (1975)
  • L. Helson et al., "Effect of Tumor Necrosis Factor on Heterotransplanted Human Tumors," Exp. Cell Biol., 47, pp. 53-60 (1979)
  • J. B. Hibbs, Jr., "The Macrophage As A Tumoricidal Effector Cell: A Review of In Vivo and In Vitro Studies On The Mechanism Of The Activated Macrophage Nonspecific Cytotoxic Reaction", in The Macrophage In Neoplasia, ed. M. A. Fink, pp. 83-111 (1976)
  • M. K. Hoffmann et al., "Serum Containing Endotoxin-Induced Tumour Necrosis Factor Substitutes For Helper T-Cells," Nature, 263, pp. 416-417 (1976)
  • M. K. Hoffmann et al., "Endotoxin-induced Serum Factor Controlling Differentiation of Bone Marrow Derived Lymphocytes", Proc. Natl. Acad. Sci. USA, 74, pp. 1200-1203 (1977)
  • M. K. Hoffmann et al., "Induction and Immunological Properties of Tumor Necrosis Factor", J. Reticuloendothelial. Soc., 23, pp. 307-319 (1978)
  • A. Itoh et al., "Induction Of TNF-like Factor By Murine Macrophage-like cell line J774.1 On Treatment With Sarcophaga lectin," FEBS, 175, pp. 59-62 (1984)
  • N. Kiger et al., "Tumor-Necrotizing Serum Production By Administration Of BCG+Pseudomonas: Its Application In Treatment Of Fibrosarcoma In Mice," Recent Results Cancer Res., 75, pp. 220-225 (1980)
  • R. G. Kilbourn et al., "Activated Macrophages Secrete A Soluble Factor That Inhibits Mitochondrial Respiration Of Tumor Cells," Journal Of Immunology, 133, pp. 2577-2581 (1984)
  • F. C. Kull, Jr. and P. Cuatrecasas, "Possible Requirement of Internalization in the Mechanism of In Vitro Cytotoxicity in Tumor Necrosis Serum," Cancer Research, 41, pp. 4885-4890 (1981)
  • F. C. Kull, Jr. and P. Cuatrecasas, "Preliminary characterization Of The Tumor Cell Cytotoxin In Tumor Necrosis Serum," Journal Of Immunology, 126, pp. 1279-1283 (1981)
  • D. N. Mannel et al., "Generation And Characterization Of A Lipopolysaccharide-Induced and Serum-Derived Cytotoxic Factor For Tumor Cells", Infect. Immun., 28, pp. 204-211 (1980)
  • D. N. Mannel et al., "Macrophages as a Source of Tumoricidal Activity (Tumor Necrotizing Factor)," Infection and Immunity, 30, pp. 523-530 (1980)
  • D. N. Mannel et al., "Inhibition Of Nonspecific Tumoricidal Activity By Activated Macrophages With Antiserum Against A Soluble Cytotoxic Factor," Infection and Immunity, 33, pp. 156-164 (1981)
  • N. Matthews and J. F. Watkins, "Tumour-Necrosis Factor From The Rabbit. I. Mode of Action, Specificity and Physicochemical properties", Br. J. Cancer, 38, pp. 302-309 (1978)
  • N. Matthews, "Tumour Necrosis Factor From The Rabbit. II. Production By Monocytes", Br. J. Cancer, 38, pp. 310-315 (1978)
  • N. Matthews, "Tumor-Necrosis Factor From The Rabbit. III. Relationship To Interferons," Br. J. Cancer, 40, pp. 534-539 (1979)
  • N. Matthews et al., "Tumour Necrosis Factor From The Rabbit. IV. Purification And Chemical characterization," Br. J. Cancer, 42, pp. 416-422 (1980)
  • N. Matthews, "Tumour Necrosis Factor From The Rabbit. In Vivo Activity And Sites Of Synthesis," Br. J. Cancer, 44, p. 294 (1981)
  • N. Matthews, "Production of an Anti-Tumour Cytotoxin By Human Monocytes," Immunology, 44, p. 135 (1981)
  • N. Matthews, "Production of an Anti-Tumor Cytotoxin by Human Monocytes: Comparison of Endotoxin, Interferons and Other agents as Inducers," Br. J. Cancer, 45, pp. 615-617 (1982)
  • N. Matthews, "Anti-tumour Cytotoxin From Macrophages: No Correlation Between Cytotoxin Adsorption By Tumour Cell Lines And Their Cytotoxin Susceptibility," Immunology, 53, pp. 537-543 (1984)
  • M. S. Meltzer and Gerald L. Bartlett, "Cytotoxicity in vitro by Products of Specifically Stimulated Spleen Cells: Susceptibility of Tumor Cells and Normal Cells," J. Natl. Cancer Inst., 49, p. 1439 (1972)
  • M. Mihara et al., "Immunopharmacological Study On Tumor Necrosis Factor," Jpn. J. Pharmacol., 36, 49P (1984)
  • M. Lynne Neale and N. Matthews, "Antimicrobial Effects Of A Macrophage-Derived Cytotoxin From The Serum Of BCG-Prime Rabbits (Tumour Necrosis Serum)" Med. Microbiol., 17, pp. 211-213 (1984)
  • H. F. Oettgen et al., "Endotoxin-Induced Tumor Necrosis Factor," Recent Results in Cancer Research.75. Cancer Chemo- And Immuno-pharmacology, pp. 207-212 (1980)
  • L. J. Old, "Tumor Necrosis Factor," Clinical Bulletin, 6, pp. 118-120 (1976)
  • L. Old, "Cancer Immunology: The Search for Specificity--G. H. A. Clowes Memorial Lectures" Cancer Research, 41, pp. 361-375 (1981)
  • H. G. Opitz et al., "Inhibition of a 3 H-Thymidine Incorporation of Lymphocytes by a Soluble Factor from Macrophages," Cell. Immunol., 16, pp. 379-388 (1975)
  • J. M. Ostrove and G. E. Gifford, "Stimulatin Of RNA Synthesis in L-929 Cells By Rabbit Tumor Necrosis Factor," Proceedings Of The Society For Experimental Biology And Medicine, 160, pp. 354-358 (1979)
  • M. Parant, "Antimicrobial Resistance Enhancing Acitivity Of Tumor Necrosis Serum Factor Induced By Endotoxin In BCG-Treated Mice," Recent Results Cancer Res., 75, pp. 213-219 (1980)
  • V. J. Pasanen, "In Vitro Enhancement of Natural Cytotoxicity--by Tumour Necrosis Serum," Scand. J. Immunol., 10, pp. 281-284 (1979)
  • W. F. Piessens et al., "Macrophages Activated In Vitro with Lymphocyte Mediators Kill Neoplastic But Not Normal Cells." J. Immunol., 114, pp. 293-299 (1975)
  • J. H. L. Playfair et al., "Endotoxin Induced `Tumour-Necrosis Serum` Kills A subpopulation Of Normal Lymphocytes In Vitro", Clin Exp. Immunol., 47, pp. 753-755 (1982)
  • M. R. Ruff and G. E. Gifford, "Purification And Physico-Chemcial Characterization Of Rabbit Tumor Necrosis Factor" Journal of Immunology, 125, pp. 1671-1677 (1980)
  • M. R. Ruff and G. E. Gifford, "Rabbit Tumor Necrosis Factor: Studies Concerned With The Mechanism Of Action," Abst. Ann. Meeting Am. Soc. Microbiol., 80 (1980)
  • M. R. Ruff and G. E. Gifford, "Rabbit Tumor Necrosis Factor: Mechanism Of Action", Infection and Immunity, 31, pp. 380-385 (1981)
  • N. Satomi et al., "Research On The Production Site Of Tumor Necrosis Factor (TNF)," Japan J. Exp. Med., 51, pp. 317-322 (1981)
  • C. C. Stewart et al., "Interaction of Macrophages with Tumor Cells," Adv. Exp. Med. Biol., 73B, pp. 423-433 (1976)
  • K. Suyama et al., "Action of Tumor Necrosis Factor (TNF) On Friend Erythroleukemic Cells In Vitro," Fed. Proc., 41(3), Abstract 2408 (1982)
  • J. Taverne et al., "Endotoxin-Induced Serum Factor Kills Malarial Parasites In Vitro," Infection And Immunity, 33, pp. 83-89 (1981)
  • J. Taverne et al., "Differential Sensitivity In Vivo Of Lethal and Non Lethal Malarial Parasites to Endotoxin-Induced Serum Factor," Infection And Immunity, 37, pp. 927-934 (1982)
  • J. Taverne et al. "Malarial Parasites And Tumour Cells Are Killed By The Same Component Of Tumor Necrosis Serum," Clin. Exp. Immunol., 57, pp. 293-300 (1984)
  • T. Umeda et al., "Cytotoxic Effect of Tumor Necrosis Factor On Human Lymphoytes and Specific Binding Of The Factor To The Target Cells," Cellular & Molecular Biology, 29, pp. 349-352 (1983)
  • G. Unsgaard and J. Hammerstrom, "Dissociation Between Tumour Cell Cytostatic And Immunosuppressive Capacity of Human Monocytes Activated With Lymphokines," Acta path. microbiol. scand. Sect. C, 90, pp. 73-79 (1982)
  • "Gene Cloning", ed Glover, Chapman and Hall 1984, pp. 102-104
  • "Principles of Gene Manipulation," ed Old et al, University of California Press, 1981, pp. 104-105 and 119-120
  • Fox, Nature, 314, 1985, pp. 132-133
  • Pennica et al, Nature 312, 1984, p. 724
  • Gray et al Nature 312 (5996) 1984, p. 72
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
 
Sign InRegister
Username  
Password   
forgot password?